Dr. Reddy's Laboratories share news, announcements and annual reports
NSE: DRREDDYBSE: 500124Pharmaceuticals & BiotechnologyMid Cap
Dr. Reddy's Laboratories Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1986 on BSE, May 2003 on NSE
Last close ₹1,352.00up ₹7.00 (0.52%)BSE ₹1,350.20
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,345.00.
30 Oct: open ₹1,345.00, high ₹1,363.70, low ₹1,345.00
52-week range of traded prices to 30 Oct 2026
₹1,101.00Low, 23 Jul 2026₹1,414.90High, 29 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,12,849 Cr104th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 40.30
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.91
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.59%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 6.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.15
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 17,14,05957.9% delivered
Dr. Reddy's Laboratories share news and announcements
1,702 announcements, routine notices left out, newest first. Page 29 of 35.
Jul 2012
2 Jul · Board meeting
Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2012.
Jun 2012
25 Jun · Business
Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 67,095 equity shares of Rs. 5/- each of the Company, fully paid up, on June 23, 2012, to various employees on exercise of their Stock Options as per the following details. (a) 60,526 equity shares of Rs. 5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. (b) 6,569 equity shares of Rs.5/- each underlying 6,569 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.6 Jun · Meeting
Dr. Reddy'S Laboratories Limited has informed the Exchange that the register of members and share transfer books of the Company would remain closed from July 03, 2012 to July 06, 2012 (both days inclusive) for the purpose of Annual General Meeting of the shareholders of the Company and for determining the shareholders who would be entitled for the payment of dividend, if declared at the forthcoming Annual General Meeting, scheduled to be held on July 20, 2012.5 Jun · Business
Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 180,472 equity shares of Rs. 5/- each of the Company, fully paid up, on June 01, 2012, to Non-Executive Directors / Employees on exercise of their Stock Options as per the following details. (a) 153,657 equity shares of Rs. 5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. (b) 26,815 equity shares of Rs.5/- each underlying 26,815 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.
May 2012
12 May · Disclosure
Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company in their meeting held on May 10, 2012 has granted 336,570 stock options, exercisable at par value of Rs.5/- under "Dr. Reddy's Employees Stock Option Scheme, 2002" and 58,840 stock options, exercisable at par value of Rs.5/- under "Dr. Reddy's Employees ADR Stock Option Scheme, 2007" to the employees of the Company.11 May · Consolidated Result Updates - IFRS
11 May · Dividend
Dr. Reddy'S Laboratories Limited has informed the Exchange that the Board of Directors of the Company have recommended a final dividend of Rs.13.75 (275%) per equity share of Rs.5/- face value, for the financial year 2011-12. The dividend on equity shares, if declared by the shareholders at the ensuing Annual General Meeting, will be credited/ dispatched on or after July 27, 2012.11 May · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2012 as follows: Net Sales of Rs. 660378 lacs for year ending on 31-MAR-2012 against Rs. 521804 lacs for the year ending on 31-MAR-2011. Net Profit / (Loss) of Rs. 91236 lacs for the year ending on 31-MAR-2012 against Rs. 89331 lacs for the year ending on 31-MAR-2011.
Apr 2012
16 Apr · Board meeting
Inter alia, to consider and approve the Audited Financial Results of the Company for the year ended March 31, 2012 and recommend dividend, if any, for the financial year 2011-12.
Mar 2012
Feb 2012
20 Feb · Business
Dr. Reddy'S Laboratories Limited has informed the Exchange that pursuant to Dr. Reddy'S Employees Stock Option Scheme, 2002, the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 16,295 equity shares of Rs 5/- each of the Company, fully paid up, on February 16, 2012, to Employees on exercise of their Stock Options.6 Feb · Corporate action
Dr. Reddy'S Laboratories Limited has informed the Exchange that the Board of Directors has fixed February 24, 2012 as record date for the purpose of ascertaing the debenture holders' entitlement to receive the 1st year's interest, at the rate of 9.25% per annum, On Non-convertible Debentures (NCDs) of the Company due for payment on March 24, 2012. The said interest on NCDs will be credited/ paid on March 24, 2012.3 Feb · Management
Dr. Reddy'S Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 03, 2012 based on the recommendation of the Nomination, Governance and Compensation Committee, has approved the re-appointment of Mr. Satish Reddy as Whole-time Director designated as Managing Director and Chief Operating Officer for the a period of 5 years, subject to the shareholders' approval.3 Feb · Consolidated Result Updates - IFRS
3 Feb · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2011 as follows: Net Sales of Rs. 156680 lacs for quarter ending on 31-DEC-2011 against Rs. 136479 lacs for the quarter ending on 31-DEC-2010. Net Profit / (Loss) of Rs. 10803 lacs for the quarter ending on 31-DEC-2011 against Rs. 26277 lacs for the quarter ending on 31-DEC-2010.
Jan 2012
11 Jan · Board meeting
Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2011.
Nov 2011
14 Nov · Business
Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 17,565 equity shares of Rs.5/- each of the Company, fully paid up, on November 12, 2011, to Non- Executive Director / Employees on exercise of their Stock Options as per the following details : (1) 15,165 equity shares of Rs.5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002; (2) 2,400 equity shares of Rs.5/- each underlying 2,400 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.
Oct 2011
25 Oct · Board meeting
Dr. Reddy'S Laboratories Limited has informed the Exchange that based on the recommendation of the Nomination, Governance and Compensation Committee, the Board of Directors of the Company at its meeting held on October 25, 2011, proposed for an amendment in the Dr. Reddy's Employees' Stock Option Scheme, 2002 subject to the shareholders' approval.25 Oct · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2011 as follows: Net Sales of Rs. 161256 lacs for quarter ending on 30-SEP-2011 against Rs. 127832 lacs for the quarter ending on 30-SEP-2010. Net Profit / (Loss) of Rs. 13850 lacs for the quarter ending on 30-SEP-2011 against Rs. 22020 lacs for the quarter ending on 30-SEP-2010.5 Oct · Board meeting
Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2011.
Sep 2011
8 Sep · Business
Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 50,654 equity shares of Rs.5/- each of the Company, fully paid up, on September 08, 2011, to Non- Executive Directors / Employees on exercise of their Stock Options as per the following details : (1) 44,008 equity shares of Rs.5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002; (2) 6,646 equity shares of Rs.5/- each underlying 6,646 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.